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~ Comparlaonof Troponln In Stratifying CKMB and T 
Risk for Adverse Outcomes In a Chest Pain 
Observation Unit 
$,A, DOLuca, E,S. McErlosn, F, Van Lento, W,R Peacock, M,T, Craig, 
J, DoIValIo, J,~, Rite, ~,E, NIsson, Tile Clev~li]nd Clinic Founclatlon, 
Clove/and, OH, USA 
t~ckgro~n:l: AIIhough t~0rum on.me markers are commonly used to oval. 
ultra p~tlonts with suspected coronaly oyedrome~, the rel[ttivo v~lua of oon. 
vontlonal and newer markers In prodlotlng 6hart and long.term outgoing8 
rom~ln~ uncertain, 
Mefhoda: Wo measured Troponln T (TnT) and CKMB in 315 patients 
with =usp0ctorJ coronary syndrome~ observed In o ~4 hour chest pain unit, 
Patients with croatlnlno ~2,0 wore excluded, Quantitative TaT (En:,ymon, 
Boehrlngor M~nnhotm) serum values and GKMB wor~ drawn at 0, 4, 8 
~nd 10 hours, Pr~ctlllon~t~ worn blinded to TnT, but nol CKMB, Adverse 
ot~rdl~o vonts wore dotined as infarction, rocLirrcnt Ischomla, coron~P/ 
surg0P/, atroko, GHF, doeth and 0athortortzatlon a d/or intervention, Short° 
t~rm ovonls wore (1alined ao In-hospital complig~tton~, wl~otoa~ long term 
ovont~ 0courted between disgh~rgo and a 6 month tallow-up interview, 
Re~ult~: Overall, for Aho entire cohort, short.term event8 Occurred in B,7% 
and long term ovsnts in ~4,4%, The r¢1to8 ot po~divtty ~nd rit~k el adverse 
short or long term outcomn~ are ~hown tn the t~blo: 
~KMI~-~ TaT ,01 TaT , 0,OG TaT 0.05-OAO 
Number * t%) ? I~%) IS t5 7'%) 53 Ilk,g%) 35 (11,1%,t 
~hort-To~m 42,0% 180% 106% ~0% 
Long.Term 05% O t % 4 t,5"o 35,1% 
p v~lg(~ for LT' • 00001 • 00001 .: 00001 .0.001 
• conlp~ro~l to entire cohort 
Conclusions: Few p0tionts In ~1 chest p(~n unit haY0 positive CKMB (2.2%1, 
but thoy have a Irlgh Incidence at o, dverso short and long term outcomes, TnT 
identifies a much I~ler cohort ot patients at risk lot short ~n~or long.term 
events (5,7-10,8%), ThT levels within the "high normal" range (0,05--0,10 
ng/ml) confer significant long term risk, Th0 improved sensitivity of Tat makes 
this the preterred marker tar ask stmtd,cat=on atpatients observed in a short 
stay cl~ost pain unit, 
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~ Usefulness of HemoatatlQ Marker In PredlQtlng 
Survival After Acute Myocardial Infarction 
Y,-H, Li, J.-K, Tong, W,-C, Tsai, L.-M Teal, L,.J, Lin, J.-H. Chen. National 
Chang Ktmg University Hospital, Tainan, Taiw<ln 
Blood coagulation system is found to be activated in acute myocardLal in- 
faretion (AMI). Howev0r, there am few published studies concerning the 
inlluence of hemostati~ function on survival in these patients (pts). To de- 
termine whether the initial levels o1 hemostatic markers in the early phase 
of AMI may sen/e as a risk factor for late cardiac mortality, blood samples 
were obtained from 64 pts (mean age 67 ± 11 years; 49 males) with AMI 
within 12 hours after symptom onset bolero any antithrombotio treatment. We 
measured fibrinopoptido A (FPA), prothrembin fragment 1 + 2 iF1 + 2) and 
thrembln-antithrombin complex (TAT) using ELISA method and examined 
the associations bohveen the level of these mark~r,~ and survival with Cox 
proportional hazards model. The follow up time was 27 ± 17 months and 
19 pts died of cardiac cause. Unwariate survival analysis identified FPA (p = 
0.001), F1 + 2 (p = 0,003), TAT (p = 0.003), Kdlip classification (p = 0.005) 
and left ventricular ejoction fraction (p = 0.01) as factors associated with 
mortality. In a muir var ate model, only FPA (ask ratio, 1.12; p = 0.003) and left 
Jo 
| ,  
0 
ventrleular ejection fmctton (risk ratio, 0,91; p = 0.002) wore In~lependontly 
associated with late cardiac mortality. The effect of elevated FPA on survival 
is illustrated in the Figure, 
! / 
~"e6~ • FPA<4,];~ .8/ml 
L~ ~11"~"'~"~'maNINP"ttB 
O FPA>~4 ]2 .g/.d 
T~ml~ tffmfnh~t 
In conclusi0n, elevated FPA in th0 early phase of AMI identily pt~ with 
increased risk far subsequent cardi~c morality, This ~ls~OCiation ~ppears to 
be m0opondenl at reazdual loll venlr~cul~r functi0n allot infarctl0n, 
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~ PrO~lnoMl¢ Value of Combined Elevation ot Tml~nln 
I anti C-rem:tlvg Protein in Patients With Unstable 
Coronary Artery Disease 
R.J. de Winter, R. Bholasinoh, J,P.MC. GolQolS, RW, Kostor. R Adams, 
Y. Schouton, G.T, Sanders. Acodom¢ M,;'dlcal Center, University el 
Amsmrdam, The Netherlands 
Purpose: It has been shown that in patients (pts) with unstable angina 
(UA) and non-Q-wave intarction (nQ.AMI), elevation of troponin I (Tnl) and 
C-reactive protein (CRP) has prognostic SignifiCance. We studied the vtsk 
of an adverse cardiac event in patients wilh UA or nQ-AMI who had both 
elevated Tnl and CRP, 
Methods: Pts admitted to the cardiac emergency room with chest pain 
of loss than 12 hours duration wore eligible tar the study. Senat CK .MB~ 
was measured, and pts with a peak CK.MB above 14 pg/L (twice upper limit 
of normal) who did not develop new Q.waves or bundle branch blOCk on 
the ECG were diagnosed as nQ.AML Pts were treated wiLh ~,spinn, hepann, 
/I-blockers, nitrates at the discretion at the attending physician. Both CRP 
and Tnl were measured from a bloodsample taken within 12 hrS after onset 
at symptoms, and results were kept blinded for the physicians treating the 
pts. CRP was measured with s Nephelometer (Behringwerke. Germany) with 
a cut-oft value of 5.0/~g/L, Tnl was measured with the Stratus It fluoremetnc 
enzyme immunoassay (gads) with a cut-off value of 0.4 ~4g/L, Events were 
cardiac death, recurrent AMI, recurrent UA, and PTCA or CABG that was not 
already scheduled at tt~e index admission. Follow-up (FU) was six months. 
Kaplan*Meier survival curves wore constructed and difterences in event-lree 
survival were calculated with the Log Rank test, 
Results: 96 pts were included, 61 males, mean age 63 yrs (range 34-88). 
There were 22 pts with nQ-AMI and 74 with UA. FU was 100%. There were 
31 events, 6 Cardiac deaths, 3 AMrS, 3 recurrent UA, 15 PTCA's, 4 CABG's. 
30 Pts had elevated Tnl, 36 pts had elevated CRP. 16 pts had beth Tnl 
and CRP elevated, 46 pts had both normal Tnl and CRP. Mean survival for 
elevated Tnl vs normal Tnl was 130 • 13 vs 142 :E 7 days iP = 0.21), Ior 
elevated CRP vs normal CRP 129 ~ 11 vs 143 ~ 9 days (p = 0.095), Mean 
survival tar combined elevat ~d Tnl and CRP vs none or one marker elevated 
was 106 :i 20 vs 142 :L 8 days (p = 0.009). 
Conclusion: In approximately 30% of PIs with UA or nQ-AMI, either CRP 
or Tnl is elevated on admission. Pts with combined elevation of CRP and 
Tnl have a signiticantly higher risk at experiencing an adverse cardiac event 
than pts with either one marker or no marker elevated. 
